Anti-NF-kB p65 antibody [EP2161Y]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(1 Review)
|
(30 Publications)
Rabbit Recombinant Monoclonal NF-kB p65 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 30 publications.
View Alternative Names
NFKB3, RELA, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-NF-kB p65 antibody [EP2161Y] (AB76311)
Immunocytochemistry/Immunofluorescence analysis HT-29 (human colorectal adenocarcinoma) labelling NF-kB p65 with purified ab76311 at 1/500. Cells were fixed with 4% PFA and permeabilized with 0.1% Triton X-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (ab150077). Nuclei counterstained with DAPI (blue).
Control : PBS only
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-NF-kB p65 antibody [EP2161Y] (AB76311)
Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling NF-kB p65 with purified ab76311 at 1/1000 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-NF-kB p65 antibody [EP2161Y] (AB76311)
Flow Cytometry analysis of HT-29 (Human colorectal adenocarcinoma epithelial cell) cells labeling NF-kB p65 with purified ab76311 at 1/1000 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- WB
Supplier Data
Western blot - Anti-NF-kB p65 antibody [EP2161Y] (AB76311)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : NF-κB p65 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : A431 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab76311 observed at 70 kDa. Red - ab8245 loading control, observed at 37 kDa.
ab76311 was shown to specifically react with NF-κB p65 in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when NF-κB p65 knockout samples were used. Wild-type and NF-κB p65 knockout samples were subjected to SDS-PAGE. ab76311 (NF-κB p65) and ab8245 (loading control to GAPDH) were both diluted 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-NF-kB p65 antibody [EP2161Y] (ab76311)
Predicted band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-NF-kB p65 antibody [EP2161Y] (AB76311)
All lanes:
Western blot - Anti-NF-kB p65 antibody [EP2161Y] (ab76311) at 1/20000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
Daudi cell lysate at 10 µg
Lane 3:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 60 kDa
Observed band size: 70 kDa
false
Related conjugates and formulations (3)
-
Anti-NF-kB p65 antibody [EP2161Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-NF-kB p65 antibody [EP2161Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-NF-kB p65 antibody [EP2161Y]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NF-kB p65 acts as part of the larger NF-kB complex usually forming a heterodimer with other family members like p50. This complex translocates to the nucleus upon activation where it binds specific DNA sequences to regulate gene expression. The p65 subunit is essential for transactivating target genes involved in immune and inflammatory responses. Its regulation is important for proper cellular functioning especially in the maintenance of immune homeostasis and inflammatory response.
Pathways
NF-kB p65 participates in critical pathways like the NF-kB signaling and Toll-like receptor pathways. These pathways are fundamental for initiating immune responses and contribute to the regulation of apoptosis and cellular stress responses. In the context of these pathways the IKK complex plays a pivotal role in NF-kB activation leading to the phosphorylation and subsequent degradation of inhibitors that retain NF-kB p65 in the cytoplasm therefore allowing its movement to the nucleus.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (30)
Recent publications for all applications. Explore the full list and refine your search
Journal of dental sciences 20:1579-1589 PubMed40654486
2025
Applications
Unspecified application
Species
Unspecified reactive species
Allergologia et immunopathologia 53:112-122 PubMed39786883
2025
Applications
Unspecified application
Species
Unspecified reactive species
Toxics 12: PubMed39195700
2024
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 19:20240991 PubMed39091610
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:17429 PubMed39075107
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 28: PubMed37446793
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:1047236 PubMed36699078
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 50: PubMed35762318
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 21:1599-1618 PubMed35404759
2022
Applications
Unspecified application
Species
Unspecified reactive species
Folia neuropathologica 59:335-349 PubMed35114774
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com